Showing results 12 to 31 of 33
< previous
next >
| Issue Date | Title | Author(s) |
| 2015 | Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE | Greenhalgh, J; Longworth, L; Crossan, C; Singh, J; Bagust, A; Beale, S; Richardson, M; Banks, L; Kotas, E; Hall, M |
| 27-Apr-2024 | Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model | Morea, A; Saravi, S; Sisu, C; Hall, M; Tosi, S; Karteris, E; Storlazzi, CT |
| 27-Dec-2022 | Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer | Kerslake, R; Panfilov, S; Mustafa, N; Hall, M; Kyrou, I; Randeva, H; Karteris, E; Godfrey, R |
| 2023 | Exploring novel strategies for assessing response to treatment in patients with advanced ovarian cancer, in particular the role and potential of non-haemopoetic circulating cells and DECT imaging | Alizzi, Zena |
| 2-Sep-2020 | H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival | Saravi, S; Katsuta, E; Jeyaneethi, J; Amin, HA; Kaspar, M; Takabe, K; Pados, G; Drenos, F; Hall, M |
| 10-Aug-2020 | Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients | Carter, TJ; Jeyaneethi, J; Kumar, J; Karteris, E; Glynne-Jones, R; Hall, M |
| 8-Nov-2017 | Identification of novel cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers | Chudasama, D; Bo, V; Hall, M; Anikin, V; Jeyaneethi, J; Gregory, J; Pados, G; Tucker, A; Harvey, A; Pink, R; Karteris, E |
| 5-May-2021 | Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer | Zahra, A; Dong, Q; Hall, M; Jeyaneethi, J; Silva, E; Karteris, E; Sisu, C |
| 4-Aug-2023 | Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: Association with treatment outcomes | Alizzi, Z; Saravi, S; Khalique, S; Mcdonald, T; Karteris, E; Hall, M |
| 15-Nov-2016 | Identifying gene–gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts | De, R; Verma, SS; Holzinger, E; Hall, M; Burt, A; Carrell, DS; Crosslin, DR; Jarvik, GP; Kuivaniemi, H; Kullo, IJ; Lange, LA; Lanktree, MB; Larson, EB; North, KE; Reiner, AP; Tragante, V; Tromp, G; Wilson, JG; Asselbergs, FW; Drenos, F; Moore, JH; Ritchie, MD; Keating, B; Gilbert-Diamond, D |
| 2-Feb-2022 | In Silico Study to predict the structural and functional consequences of SNPs on biomarkers of ovarian cancer (OC) and BPA exposure-associated OC | Zahra, A; Hall, M; Chatterjee, J; Sisu, C; Karteris, E |
| 2023 | Investigation of the role of asprosin and downstream glycolytic molecules in ovarian cancer | Kerslake, Rachel |
| 12-Sep-2019 | Kinase inhibitors and ovarian cancer | Katopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E |
| 7-Mar-2019 | Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications | Chudasama, D; Katopodis, P; Stone, N; Haskell, J; Sheridan, H; Gardner, B; Urnovitz, H; Schuetz, E; Beck, J; Hall, M; Barr, J; Sisu, C; Rice, A; Polychronis, A; Anikin, V; Karteris, E |
| 8-Dec-2022 | A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
| 15-Sep-2020 | Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 | Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 15-Sep-2021 | Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of Brca2 Status | Saravi, S; Alizzi, Z; Tosi, S; Hall, M; Karteris, E |
| 1-Mar-2016 | The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro | Mankarious, A; Dave, F; Pados, G; Tsolakidis, D; Gidron, Y; Pang, Y; Thomas, P; Hall, M; Karteris, E |
| 2018 | Prognostic value of the DNA integrity index in patients with malignant lung tumors | Chudasama, DY; Aladag, Z; Felicien, MI; Hall, M; Beeson, J; Asadi, N; Gidron, Y; Karteris, E; Anikin, VB |
